Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PRECIGEN, INC.PGEN · Entity 4356 | Chief Operating Officer | August 21, 2026 | August 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PRECIGEN, INC.
Report date August 21, 2026 · Filed August 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 468,865 |
Ending reported balance
After 2026-08-25 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2026-08-21 · Exercise / conversion · Acquired 34,658 · Balance 499,670 Row 2 · 2026-08-21 · Sale · Disposed 34,658 · Balance 465,012 F1: Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person. Row 3 · 2026-08-23 · Exercise / conversion · Acquired 7,500 · Balance 472,512 F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Row 4 · 2026-08-23 · Tax withholding · Disposed 3,647 · Balance 468,865 F3: Represents the number of shares of Precigen common stock withheld by the Issuer to satisfy income tax withholding obligations in connection with the settlement of the RSUs. Row 5 · 2026-08-25 · Exercise / conversion · Acquired 15,342 · Balance 484,207 Row 6 · 2026-08-25 · Sale · Disposed 15,342 · Balance 468,865 F1: Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person. |
| Option to Purchase Common Stock (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.33 · Expires 2032-02-02 | Direct | 88,646 |
Reported balance
After 2026-08-21 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-08-21 · Exercise / conversion · Disposed 34,658 · Balance 88,646 F4: The stock options are fully vested. |
| Option to Purchase Common Stock (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.33 · Expires 2032-02-02 | Direct | 73,304 |
Reported balance
After 2026-08-25 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-08-25 · Exercise / conversion · Disposed 15,342 · Balance 73,304 F4: The stock options are fully vested. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 57,292 |
Reported balance
After 2026-08-23 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-08-23 · Exercise / conversion · Disposed 7,500 · Balance 57,292 F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F5: Represents 1/24 of the RSUs granted on June 26, 2025 that vested on August 23, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
F3: Represents the number of shares of Precigen common stock withheld by the Issuer to satisfy income tax withholding obligations in connection with the settlement of the RSUs.
F4: The stock options are fully vested.
F5: Represents 1/24 of the RSUs granted on June 26, 2025 that vested on August 23, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 02, 2023 Filed Aug 4, 2023 23:06 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionCommon Stock | 15,480 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-23-011611 · dp198070_4-shah.xml · nonDerivative · entry 1 Shah Rutul R · CIK 0001947221 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,477 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| April 28, 2023 Filed May 2, 2023 21:57 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0000950103-23-006765 · dp193271_4-shah.xml · derivative · entry 1 Shah Rutul R · CIK 0001947221 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2033-04-28 F1 · derivative.exercise_date: The options vest 25% on April 28, 2024 and in equal monthly installments for three years thereafter. Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:12 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 40,409 | $0.00 Strike: $0.96 | $0.00 |
DisclosureSEC source: 0000950103-23-004827 · dp191373_4-shah.xml · derivative · entry 4 Shah Rutul R · CIK 0001947221 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,409 Underlying: Common Stock · 40,409 shares Expires 2033-03-24 Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:12 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionRestricted Stock Units · Derivative | 30,960 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-004827 · dp191373_4-shah.xml · derivative · entry 3 Shah Rutul R · CIK 0001947221 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,920 Underlying: Common Stock · 30,960 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: Represents 1/3 of the RSUs granted on March 24, 2023 that vested immediately. F3 · derivative.expiration_date: Represents 1/3 of the RSUs granted on March 24, 2023 that vested immediately. Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:12 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantRestricted Stock Units · Derivative | 92,880 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-004827 · dp191373_4-shah.xml · derivative · entry 2 Shah Rutul R · CIK 0001947221 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,880 Underlying: Common Stock · 92,880 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2 · derivative.exercise_date: 1/3 of the RSUs vested immediately upon the grant date, and the remaining RSUs vest in four equal installments on each of August 2, 2023, August 9, 2023, August 16, 2023 and August 23, 2023. F2 · derivative.expiration_date: 1/3 of the RSUs vested immediately upon the grant date, and the remaining RSUs vest in four equal installments on each of August 2, 2023, August 9, 2023, August 16, 2023 and August 23, 2023. Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:12 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionCommon Stock | 30,960 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-23-004827 · dp191373_4-shah.xml · nonDerivative · entry 1 Shah Rutul R · CIK 0001947221 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,997 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| January 27, 2023 Filed Jan 31, 2023 00:27 UTC | PRECIGEN, INC. PGEN · Entity 4356 | PurchaseCommon Stock | 9,142 | $1.75 | $15,998.50 |
DisclosureSEC source: 0000950103-23-001416 · dp187976_4-shah.xml · nonDerivative · entry 1 Shah Rutul R · CIK 0001947221 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,037 F1 · kind: The reporting person purchased shares of Precigen common stock ("Common Stock") in connection with the issuer's follow-on offering, which closed on January 27, 2023. The purchase price is the offering price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.